Open AccessRandomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia
Author(s) -
J. F. Zeidner,
M. C. Foster,
Amanda L. Blackford,
M. R. Litzow,
L. E. Morris,
S. A. Strickland,
J. E. Lancet,
P. Bose,
M. Y. Levy,
R. Tibes,
I. Gojo,
C. D. Gocke,
G. L. Rosner,
R. F. Little,
J. J. Wright,
L. A. Doyle,
B. D. Smith,
J. E. Karp
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ee6n-g457
Subject(s) - cytarabine , mitoxantrone , daunorubicin , myeloid leukemia , medicine , leukemia , oncology , cancer research , chemotherapy